{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T15:40:34Z","timestamp":1783698034209,"version":"3.55.0"},"reference-count":45,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,8,16]],"date-time":"2021-08-16T00:00:00Z","timestamp":1629072000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Genetics and Metabolism"],"published-print":{"date-parts":[[2022,2]]},"DOI":"10.1016\/j.ymgme.2021.07.008","type":"journal-article","created":{"date-parts":[[2021,7,25]],"date-time":"2021-07-25T09:28:37Z","timestamp":1627205317000},"page":"143-153","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["MPS VI associated ocular phenotypes in an MPS VI murine model and the therapeutic effects of odiparcil treatment"],"prefix":"10.1016","volume":"135","author":[{"given":"Eugeni","family":"Entchev","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophie","family":"Antonelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Virginie","family":"Mauro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolas","family":"Cimbolini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ingrid","family":"Jantzen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aurelie","family":"Roussey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeanne-Marie","family":"Germain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haoyue","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Michel","family":"Luccarrini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivier","family":"Lacombe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah P.","family":"Young","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurence","family":"Feraille","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mireille","family":"Tallandier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ymgme.2021.07.008_bb0005","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1177\/2326409813517663","article-title":"Lysosomal storage diseases","volume":"2","author":"Alroy","year":"2014","journal-title":"J. Inborn Error Metab. Screen."},{"key":"10.1016\/j.ymgme.2021.07.008_bb0010","series-title":"The Metabolic and Molecular Bases of Inherited Disease","first-page":"3421","article-title":"The mucopolysaccharidoses","author":"Neufeld","year":"2001"},{"key":"10.1016\/j.ymgme.2021.07.008_bb0015","series-title":"Biomarkers in Inborn Errors of Metabolism","first-page":"191","article-title":"Chapter 9 - Lysosomal storage disorders: Mucopolysaccharidoses","author":"Yu","year":"2017"},{"issue":"Suppl. 5","key":"10.1016\/j.ymgme.2021.07.008_bb0020","article-title":"Pathogenesis of skeletal and connective tissue involvement in the mucopolysaccharidoses: glycosaminoglycan storage is merely the instigator","volume":"50","author":"Clarke","year":"2011","journal-title":"Rheumatol. (Oxford, England)"},{"key":"10.1016\/j.ymgme.2021.07.008_bb0025","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1007\/s10545-011-9359-8","article-title":"Cardiac disease in patients with mucopolysaccharidosis: presentation, diagnosis and management","volume":"34","author":"Braunlin","year":"2011","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.ymgme.2021.07.008_bb0030","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1038\/sj.eye.6701921","article-title":"The ocular features of the mucopolysaccharidoses","volume":"20","author":"Ashworth","year":"2006","journal-title":"Eye (London, England)"},{"key":"10.1016\/j.ymgme.2021.07.008_bb0035","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/1750-1172-5-5","article-title":"Mucopolysaccharidosis VI","volume":"5","author":"Valayannopoulos","year":"2010","journal-title":"Orphanet J. Rare Dis."},{"key":"10.1016\/j.ymgme.2021.07.008_bb0040","doi-asserted-by":"crossref","first-page":"385","DOI":"10.2741\/4490","article-title":"Mucopolysaccharidosis VI: pathophysiology, diagnosis and treatment","volume":"22","author":"Harmatz","year":"2017","journal-title":"Front. Biosci. (Landmark Ed.)"},{"key":"10.1016\/j.ymgme.2021.07.008_bb0045","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.ymgme.2008.02.012","article-title":"Maroteaux-Lamy syndrome: functional characterization of pathogenic mutations and polymorphisms in the arylsulfatase B gene","volume":"94","author":"Garrido","year":"2008","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2021.07.008_bb0050","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1136\/bjophthalmol-2017-311749","article-title":"Variability in the ocular phenotype in mucopolysaccharidosis","volume":"103","author":"Sornalingam","year":"2019","journal-title":"Br. J. Ophthalmol."},{"key":"10.1016\/j.ymgme.2021.07.008_bb0055","first-page":"4692859","article-title":"Fundoscopic changes in Maroteaux-Lamy Syndrome","volume":"2019","author":"Magalh\u00e3es","year":"2019","journal-title":"Case Rep. Ophthalmol. Med."},{"key":"10.1016\/j.ymgme.2021.07.008_bb0060","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.2147\/OPTH.S78368","article-title":"Ocular manifestations and management recommendations of lysosomal storage disorders I: mucopolysaccharidoses","volume":"9","author":"Fenzl","year":"2015","journal-title":"Clin. Ophthalmol. (Auckland, N.Z.)"},{"key":"10.1016\/j.ymgme.2021.07.008_bb0065","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1111\/j.1442-9071.2010.02364.x","article-title":"Ocular manifestations in the mucopolysaccharidoses - a review","volume":"38","author":"Ashworth","year":"2010","journal-title":"Clin. Exp. Ophthalmol."},{"key":"10.1016\/j.ymgme.2021.07.008_bb0070","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1006\/exer.1998.0622","article-title":"Altered corneal stromal matrix organization is associated with mucopolysaccharidosis I, III and VI","volume":"68","author":"Alroy","year":"1999","journal-title":"Exp. Eye Res."},{"key":"10.1016\/j.ymgme.2021.07.008_bb0075","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1111\/j.1651-2227.2007.00211.x","article-title":"Animal models for mucopolysaccharidosis disorders and their clinical relevance","volume":"96","author":"Haskins","year":"2007","journal-title":"Acta Paediatr. (Oslo, Norway 1992)"},{"key":"10.1016\/j.ymgme.2021.07.008_bb0080","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1172\/JCI119208","article-title":"Enzyme replacement therapy from birth in a feline model of mucopolysaccharidosis type VI","volume":"99","author":"Crawley","year":"1997","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.ymgme.2021.07.008_bb0085","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1172\/JCI935","article-title":"Two mutations within a feline mucopolysaccharidosis type VI colony cause three different clinical phenotypes","volume":"101","author":"Crawley","year":"1998","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.ymgme.2021.07.008_bb0090","doi-asserted-by":"crossref","first-page":"1864","DOI":"10.1172\/JCI118617","article-title":"Enzyme replacement therapy in a feline model of Maroteaux-Lamy syndrome","volume":"97","author":"Crawley","year":"1996","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.ymgme.2021.07.008_bb0095","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1006\/geno.1995.9962","article-title":"Mucopolysaccharidosis type VI in rats: isolation of cDNAs encoding arylsulfatase B, chromosomal localization of the gene, and identification of the mutation","volume":"29","author":"Kunieda","year":"1995","journal-title":"Genomics"},{"key":"10.1016\/j.ymgme.2021.07.008_bb0100","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1172\/JCI116268","article-title":"Arylsulfatase B-deficient mucopolysaccharidosis in rats","volume":"91","author":"Yoshida","year":"1993","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.ymgme.2021.07.008_bb0105","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0054459","article-title":"Pentosan polysulfate: a novel therapy for the mucopolysaccharidoses","volume":"8","author":"Schuchman","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.ymgme.2021.07.008_bb0110","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0100882","article-title":"Dose responsive effects of subcutaneous pentosan polysulfate injection in mucopolysaccharidosis type VI rats and comparison to oral treatment","volume":"9","author":"Frohbergh","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.ymgme.2021.07.008_bb0115","author":"Curtain"},{"key":"10.1016\/j.ymgme.2021.07.008_bb0120","doi-asserted-by":"crossref","first-page":"2186","DOI":"10.1002\/jbmr.3563","article-title":"The lysosomal protein arylsulfatase B is a key enzyme involved in skeletal turnover","volume":"33","author":"Pohl","year":"2018","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.ymgme.2021.07.008_bb0125","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0233032","article-title":"Odiparcil, a potential glycosaminoglycans clearance therapy in mucopolysaccharidosis VI-evidence from in vitro and in vivo models","volume":"15","author":"Entchev","year":"2020","journal-title":"PLoS One"},{"key":"10.1016\/j.ymgme.2021.07.008_bb0130","doi-asserted-by":"crossref","first-page":"5467","DOI":"10.1038\/onc.2013.483","article-title":"Arylsulfatase B regulates versican expression by galectin-3 and AP-1 mediated transcriptional effects","volume":"33","author":"Bhattacharyya","year":"2014","journal-title":"Oncogene"},{"key":"10.1016\/j.ymgme.2021.07.008_bb0135","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1093\/hmg\/ddaa006","article-title":"Enzyme replacement therapy in mice lacking arylsulfatase B targets bone remodeling cells, but not chondrocytes","volume":"29","author":"Hendrickx","year":"2020","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.ymgme.2021.07.008_bb0140","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1590\/S1415-47572010005000093","article-title":"Mucopolysaccharidosis I, II, and VI: brief review and guidelines for treatment","volume":"33","author":"Giugliani","year":"2010","journal-title":"Genet. Mol. Biol."},{"key":"10.1016\/j.ymgme.2021.07.008_bb0145","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1111\/jcpt.12136","article-title":"Current and potential therapeutic strategies for mucopolysaccharidoses","volume":"39","author":"Noh","year":"2014","journal-title":"J. Clin. Pharm. Ther."},{"key":"10.1016\/j.ymgme.2021.07.008_bb0150","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1007\/s40265-019-01147-4","article-title":"Therapeutic options for Mucopolysaccharidoses: current and emerging treatments","volume":"79","author":"Sawamoto","year":"2019","journal-title":"Drugs"},{"key":"10.1016\/j.ymgme.2021.07.008_bb0155","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.ymgme.2010.09.010","article-title":"Clinical outcomes following hematopoietic stem cell transplantation for the treatment of mucopolysaccharidosis VI","volume":"102","author":"Turbeville","year":"2011","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2021.07.008_bb0160","author":"BioMarin Pharmaceutical Inc"},{"key":"10.1016\/j.ymgme.2021.07.008_bb0165","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1136\/bjo.2010.179937","article-title":"Diagnosis and management of ophthalmological features in patients with mucopolysaccharidosis","volume":"95","author":"Ferrari","year":"2011","journal-title":"Br. J. Ophthalmol."},{"key":"10.1016\/j.ymgme.2021.07.008_bb0170","doi-asserted-by":"crossref","first-page":"1860","DOI":"10.2174\/138920111798376932","article-title":"Substrate reduction therapies for mucopolysaccharidoses","volume":"12","author":"Jak\u00f3bkiewicz-Banecka","year":"2011","journal-title":"Curr. Pharm. Biotechnol."},{"key":"10.1016\/j.ymgme.2021.07.008_bb0175","doi-asserted-by":"crossref","first-page":"1989","DOI":"10.1111\/j.1538-7836.2006.02064.x","article-title":"A comparison of the beta-D-xyloside, odiparcil, to warfarin in a rat model of venous thrombosis","volume":"4","author":"Toomey","year":"2006","journal-title":"J. Thromb. Haemostasis"},{"key":"10.1016\/j.ymgme.2021.07.008_bb0180","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1038\/nprot.2010.48","article-title":"High-performance liquid chromatography-mass spectrometry for mapping and sequencing glycosaminoglycan-derived oligosaccharides","volume":"5","author":"Volpi","year":"2010","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.ymgme.2021.07.008_bb0185","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1373\/clinchem.2010.161141","article-title":"Analysis of glycosaminoglycans in cerebrospinal fluid from patients with mucopolysaccharidoses by isotope-dilution ultra-performance liquid chromatography-tandem mass spectrometry","volume":"57","author":"Zhang","year":"2011","journal-title":"Clin. Chem."},{"key":"10.1016\/j.ymgme.2021.07.008_bb0190","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.3390\/jcm8091467","article-title":"Ophthalmological findings in Mucopolysaccharidoses","volume":"8","author":"Tomatsu","year":"2019","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.ymgme.2021.07.008_bb0195","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1076\/ceyr.28.1.63.23494","article-title":"The effects of forward light scattering on the multifocal electroretinogram","volume":"28","author":"Tam","year":"2004","journal-title":"Curr. Eye Res."},{"issue":"Pt 6","key":"10.1016\/j.ymgme.2021.07.008_bb0200","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1038\/eye.1988.114","article-title":"Electrophysiological testing of eyes with opaque media","volume":"2","author":"Galloway","year":"1988","journal-title":"Eye (London, England)"},{"key":"10.1016\/j.ymgme.2021.07.008_bb0205","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.1002\/ajmg.a.36584","article-title":"Natural history and galsulfase treatment in mucopolysaccharidosis VI (MPS VI, Maroteaux-Lamy syndrome)--10-year follow-up of patients who previously participated in an MPS VI survey study","volume":"164A","author":"Giugliani","year":"2014","journal-title":"Am. J. Med. Genet. A"},{"key":"10.1016\/j.ymgme.2021.07.008_bb0210","doi-asserted-by":"crossref","first-page":"3648","DOI":"10.1167\/iovs.08-2941","article-title":"Dimensions and morphology of the cornea in three strains of mice","volume":"50","author":"Henriksson","year":"2009","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.ymgme.2021.07.008_bb0215","doi-asserted-by":"crossref","first-page":"10396","DOI":"10.1038\/s41598-019-46836-y","article-title":"Measuring vision using innate behaviours in mice with intact and impaired retina function","volume":"9","author":"Storchi","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ymgme.2021.07.008_bb0220","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1016\/j.ymthe.2020.04.004","article-title":"Intrastromal gene therapy prevents and reverses advanced corneal clouding in a canine model of Mucopolysaccharidosis I","volume":"28","author":"Miyadera","year":"2020","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymgme.2021.07.008_bb0225","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.ymthe.2004.08.027","article-title":"Liver-directed neonatal gene therapy prevents cardiac, bone, ear, and eye disease in mucopolysaccharidosis I mice","volume":"11","author":"Liu","year":"2005","journal-title":"Mol. Ther."}],"container-title":["Molecular Genetics and Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096719221007599?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096719221007599?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T23:51:39Z","timestamp":1761090699000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1096719221007599"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2]]},"references-count":45,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2022,2]]}},"alternative-id":["S1096719221007599"],"URL":"https:\/\/doi.org\/10.1016\/j.ymgme.2021.07.008","relation":{},"ISSN":["1096-7192"],"issn-type":[{"value":"1096-7192","type":"print"}],"subject":[],"published":{"date-parts":[[2022,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"MPS VI associated ocular phenotypes in an MPS VI murine model and the therapeutic effects of odiparcil treatment","name":"articletitle","label":"Article Title"},{"value":"Molecular Genetics and Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ymgme.2021.07.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}